|Articles|July 11, 2018
Synteract Acquires Dermatology Specialist CRO Cu-Tech
Advertisement
Synteract, a CRO providing full-service Phase I-IV clinical trials, has acquired Cu-Tech, a dermatology specialist CRO. With this acquirement, Synteract has created a dedicated center of dermatology development.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
3
Breaking Out of AI Pilot Mode in Clinical Development
4
ACT Brief: Community Sites Prove Readiness, Platformization Reshapes Clinical Ops, and AI Targets Precision Care at JPM
5